UK markets closed

Editas Medicine, Inc. (EDIT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.49-0.06 (-1.08%)
At close: 04:00PM EDT
5.55 +0.06 (+1.09%)
After hours: 06:32PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts14141515
Avg. Estimate-0.67-0.67-2.66-2.74
Low estimate-1.09-1.11-3.83-4.51
High estimate-0.44-0.46-1.84-1.72
Year ago EPS-0.71-0.56-2.02-2.66
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts12121515
Avg. Estimate7.9M6M35.66M26.48M
Low estimateN/AN/AN/AN/A
High estimate27.5M14.7M78.7M53.86M
Year ago sales9.85M4.17M78.12M35.66M
Sales growth (year/est)-19.80%43.90%-54.40%-25.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.78-0.76-0.57-0.54
Actual EPS-0.71-0.56-0.55-0.23
Difference0.070.20.020.31
Surprise %9.00%26.30%3.50%57.40%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.67-0.67-2.66-2.74
7 days ago-0.66-0.67-2.65-2.67
30 days ago-0.67-0.67-2.66-2.74
60 days ago-0.6-0.59-2.35-2.34
90 days ago-0.59-0.58-2.38-2.34
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesEDITIndustrySector(s)S&P 500
Current qtr.5.60%N/AN/AN/A
Next qtr.-19.60%N/AN/AN/A
Current year-31.70%N/AN/AN/A
Next year-3.00%N/AN/AN/A
Next 5 years (per annum)1.70%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A